The Healthcare Technology Report is pleased to announce The Top 25 Healthcare AI Executives of 2025. These leaders are applying artificial intelligence to some of the most persistent challenges in healthcare—accelerating drug discovery, improving diagnostic accuracy, and supporting overburdened clinical teams. Their companies work across disciplines, developing generative models for biology, embedding intelligence into clinical workflows, and creating platforms that make sense of fragmented data at scale. Collectively, they are helping move AI from proof-of-concept to infrastructure.
This year’s awardees include physician-entrepreneurs, academic researchers, and technical founders, many of whom were applying machine learning to healthcare before it was standard practice. What connects them is not a single application or technology, but a shared belief that AI, when applied rigorously and responsibly, can help improve patient outcomes.
Among this year’s awardees, we recognize Sameer Ather, CEO and Co-Founder of XpertDox, who brings over two decades of clinical and technical experience to the development of XpertCoding, an AI-powered autonomous medical coding solution that helps healthcare organizations close billing gaps, reduce delays, and mitigate audit risk. Dr. Chris Mansi, Co-Founder and CEO of Viz.ai, is leveraging his background as a neurosurgeon and cognitive scientist to lead a platform now used in over 1,700 hospitals across the U.S. and Europe to accelerate diagnosis and streamline care coordination. Alice Zhang, Co-Founder and CEO of Verge Genomics, is applying machine learning to one of the industry’s largest proprietary patient genomics datasets, with the goal of advancing drug development for complex neurodegenerative diseases such as ALS, Parkinson’s, and Alzheimer’s.
As AI becomes embedded across the healthcare system—from research labs to hospital floors—these executives are setting the standard for what meaningful, responsible innovation looks like. This year’s awardees were selected based on their career track records and contributions to advancing AI in healthcare. Please join us in recognizing The Top 25 Healthcare AI Executives of 2025.
1. Brendan Frey
Company: Deep Genomics
Title: Founder & Chief Innovation Officer
Brendan Frey is the Founder and Chief Innovation Officer of Deep Genomics and Co-Founder of the Vector Institute for Artificial Intelligence. Deep Genomics is a multidisciplinary team of AI and biology scientists dedicated to pioneering a new era of genomic research and development through the company’s BigRNA model, the first AI foundation model for decoding RNA biology and designing therapeutics.
Frey has developed AI systems that can accurately predict normal and pathological cell and genome biology, facilitating biomedical breakthroughs. This work led to the discovery of new biology, the founding of Deep Genomics in 2015, the first AI system for predicting pathogenic mutations and identifying therapeutic targets, and the development of new therapeutic candidates for patients with genetic disorders. Frey holds a bachelor’s degree in electrical engineering from the University of Calgary, a master’s degree in electrical and computer engineering from the University of Manitoba, and a PhD in machine learning from the University of Toronto.
2. Alexandre Attia
Company: AZmed
Title: Co-Founder and CTO
Alexandre Attia is the Co-Founder and CTO of AZmed, a company developing deep learning tools to assist in medical imaging. Its AI software, Rayvolve, helps radiologists detect fractures on X-rays and is fully integrated into existing clinical workflows, allowing for faster diagnoses without requiring changes to physicians’ routines. Attia has close to a decade of experience working at the intersection of machine learning and applied healthcare technology.
Before joining AZmed, Attia was a VP and co-founder at Genius Global, a student entrepreneurship network that promotes startup culture through workshops, pitch competitions, and community-building events. Attia graduated from ENS Paris-Saclay with a master’s degree in machine learning and computer science, and from École nationale des ponts et chaussées with a bachelor’s degree and master’s degree in industrial engineering and computer science.
3. Daphne Koller
Company: insitro
Title: Founder and CEO
Daphne Koller is the CEO and Founder of insitro, a machine learning-driven drug discovery and development company that aims to transform the way drugs are discovered and delivered to patients. Her work sits at the intersection of machine learning and biomedicine—two fields that historically haven’t converged due to gaps in high-quality data and cross-disciplinary expertise. At insitro, she’s focused on bridging those gaps to accelerate the design of safer, more effective therapies.
Before founding insitro, Koller co-founded and led Coursera as co-CEO and president, helping establish it as one of the most prominent online education platforms. She also co-founded Engageli, a digital learning startup. Koller spent 18 years on the Stanford University faculty as the Rajeev Motwani Professor of Computer Science and remains an adjunct faculty member. She holds a bachelor’s degree in mathematics and computer science as well as a master’s degree in computer science from The Hebrew University of Jerusalem, and a PhD in computer science from Stanford University.
4. Eric Lefkofsky
Company: Tempus
Title: Founder and CEO
Eric Lefkofsky is the Founder and CEO of Tempus, a technology company using artificial intelligence to personalize and improve cancer care, as well as other areas of precision medicine. He is also the Co-Founder and General Partner at Lightbank, a venture capital firm investing in disruptive technology startups.
Over the course of his career, Lefkofsky has co-founded multiple companies, including Pathos AI, which applies machine learning to drug development; Groupon, the e-commerce platform; Mediaocean, which provides media management software; Echo Global Logistics, focused on tech-enabled transportation; and InnerWorkings, a global marketing execution firm. He also serves on the boards of The Art Institute of Chicago and Northwestern Medicine. He holds a bachelor’s degree from the University of Michigan and a JD from the University of Michigan Law School.
5. Chris Mansi
Company: Viz.ai
Title: Co-Founder and CEO
Dr. Chris Mansi is the Co-Founder and CEO of Viz.ai, a healthcare technology company applying artificial intelligence to streamline clinical workflows and accelerate diagnoses. Viz.ai’s platform is used by more than 1,700 hospitals and health systems across the U.S. and Europe to support care coordination and decision-making. In 2018, Viz.ai’s stroke detection algorithm became the first AI-powered diagnostic software to receive FDA clearance for improving patient outcomes. The company has since expanded to include 13 FDA-cleared algorithms spanning heart, lung, and brain conditions.
Mansi first got his start in 2009 as a medical doctor at the NHS. From there, he became a neurosurgeon at Queen Square & King's College Hospitals, before eventually rising to CEO of EDUSURG Ltd., an online medical education platform, prior to joining Viz.ai. Mansi holds an MBA from Stanford University, a bachelor’s degree in surgery and a master’s degree in cognitive science from the University of Cambridge, and a bachelor’s degree in medicine and surgery (MBBS) from University College London.
6. Kira Radinsky
Company: Diagnostic Robotics
Title: Co-Founder and CTO
Kira Radinsky is the Co-Founder and CTO of Diagnostic Robotics, a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients. The platform applies advanced machine learning to unstructured clinical data to support early risk detection, triage optimization, and care coordination, aiming to reduce unnecessary emergency visits and improve resource allocation. Since its founding in 2017, Diagnostic Robotics has focused on making healthcare more accessible and efficient by embedding predictive analytics into routine workflows across national health systems. Radinsky oversees both the strategic and technical direction of the company.
Before returning to her current role as CTO of Diagnostic Robotics, Radinsky served as CEO of the company from its founding through 2025, leading the development of its AI-powered care management platform. She is also the scientific co-founder of Mana.bio, an AI-driven drug delivery company focused on lipid nanoparticle development for oligonucleotide therapeutics. Earlier in her career, she held senior roles in data science at eBay and co-founded SalesPredict, which was later acquired. Radinsky earned a PhD and a bachelor’s degree in computer science from the Technion Excellence Program at the Israel Institute of Technology, where she also serves as a visiting professor.
7. Sameer Ather
Company: XpertDox
Title: CEO and Co-Founder
Sameer is a Phoenix-based physician, entrepreneur, and academic leader whose vision centers on changing how physicians are paid by eliminating incentives that reward quantity over quality. As CEO and Co-Founder of XpertDox, he leads the team with a mission-driven focus on solving complex healthcare challenges through advanced data analytics and automation. With over 20 years of experience in both clinical and technical domains, Sameer has driven the development of XpertCoding by XpertDox, an AI-powered autonomous medical coding solution for healthcare organizations to identify gaps in billing and coding, reduce charge entry lag, improve revenue cycle performance, and reduce the risk of payer audits.
Sameer earned his medical degree from King George Medical College in India and his PhD in clinical investigation from the Baylor College of Medicine. He completed cardiology training at the University of Alabama at Birmingham, where he continues to serve as an Associate Professor of Cardiovascular Disease (Hon). He is also a Fellow of the American College of Cardiology, a member of the American Medical Association, and a contributing member of the Forbes Technology Council. His 77 peer-reviewed publications have garnered more than 2,100 citations globally.
A recognized thought leader and a frequent speaker at leading healthcare forums and webinars—including the Urgent Care Association and NERUCA—Sameer brings a unique blend of clinical insight, academic depth, and entrepreneurial drive.
8. Scott Burke
Company: Verily
Title: CTO
Scott Burke is the Chief Technology Officer at Verily, where he leads the company’s software and hardware engineering, AI and data science, and UX teams in the development of innovative products and platforms that power precision health. Verily is an Alphabet data platform and technology company purpose-built to power AI for precision health. Verily offers AI-enabled solutions that transform disparate health data into insights and actions that accelerate research and improve care for individuals and communities.
Prior to Verily, Burke was co-founder and CTO of Helix, a leading population genomics company. Before Helix, Burke worked for nine years at Yahoo, most recently as senior vice president of advertising and data platforms. Burke also previously led engineering teams at two mobile startups, Seven Networks and PacketHop, and was vice president of engineering for WebMD. Burke started his career as a computational physicist at Hewlett-Packard. He holds a bachelor’s degree in physics from Harvey Mudd College in Claremont, California.
9. Alex Zhavoronkov
Company: Insilico Medicine
Title: Founder and CEO
Alex Zhavoronkov is the Founder and CEO of Insilico Medicine, a generative AI company focused on drug discovery and biomarker development. Since launching in 2014, the company has advanced programs in oncology, fibrosis, and CNS disorders, and developed widely used AI platforms like PandaOmics and Chemistry42. Insilico has nominated over 20 preclinical candidates, brought 10 into clinical trials, and reached Phase 2a with one AI-discovered and AI-designed therapeutic. Zhavoronkov has a combined background in biomedicine and computer technology.
Prior to Insilico, Zhavoronkov worked in senior roles at ATI Technologies, the Biogerontology Research Foundation, and Deep Longevity. Since 2012, he has published over 200 peer-reviewed research papers and three books. He is also the founder and co-chair of the Aging Research and Drug Discovery (ARDD) conference, a global nonprofit event focused on longevity science and drug development. Zhavoronkov graduated from Lomonosov Moscow State University with a PhD in physics, from The Johns Hopkins University with a master’s degree in biotechnology, and from Queen's University with a bachelor’s degree in computer science.
10. Elad Walach
Company: Aidoc
Title: Co-Founder and CEO
Elad Walach is the Co-Founder and CEO of Aidoc, a healthcare AI company using deep learning to help hospitals manage rising patient volumes and coordinate care more effectively. Since founding the company in 2016, Walach has led Aidoc through four funding rounds totaling $250 million and overseen the development of its AI Care Platform, which includes both in-house and third-party algorithms spanning cardiovascular and neurological care. Aidoc’s solutions are now used in over 1,200 medical facilities worldwide.
Walach began his career in the elite Israeli Defense Force technology program “Talpiot,” a highly selective academic and leadership track focused on science, technology, and national service. While he was in the Israeli Air Force, he led AI research and initiated and managed several teams focused on machine learning and computer vision projects. Walach graduated from Tel Aviv University with a master’s degree in computer science and from The Hebrew University of Jerusalem with a bachelor’s degree in computer science and physics.
11. Zachary Lipton
Company: Abridge
Title: CTO and Chief Scientific Officer
Zack Lipton is the CTO and CSO of Abridge and a professor on the machine learning faculty at Carnegie Mellon University. Abridge was founded in 2018 to power deeper understanding in healthcare. The enterprise-grade AI platform transforms medical conversations into clinically useful and billable documentation at the point of care, reducing administrative burden and clinician burnout while improving patient experiences.
Lipton’s research focuses include the theoretical and engineering foundations of robust and adaptive machine learning algorithms, applications to both prediction and decision-making problems in clinical medicine, natural language processing, and the impact of machine learning systems on society. He is also the co-author of Dive Into Deep Learning, an interactive open-source textbook that has reached millions of readers. Lipton earned a PhD and master’s degree in computer science from the University of California, San Diego, and a bachelor’s degree in mathematics and economics from Columbia University.
12. Alice Zhang
Company: Verge Genomics
Title: Co-Founder and CEO
Alice Zhang is the CEO and Co-Founder of Verge Genomics, a company using artificial intelligence to rapidly develop better drugs for diseases like ALS, Parkinson’s disease, and Alzheimer’s disease. Verge has an end-to-end technology-driven drug discovery and development platform, featuring one of the field’s largest and most comprehensive proprietary patient genomics datasets from human tissue. Verge uses machine learning to mine this data and develops these insights into new drugs using its human-centric biology and chemistry platforms.
Zhang currently sits on the board of directors at the California Life Sciences Association. She is also an angel investor and advisor for tech-enabled bio startups. Zhang holds a bachelor’s degree in molecular biology from Princeton University and studied neuroscience in the MD/PhD program at the David Geffen School of Medicine at the University of California, Los Angeles.
13. Andrew Beck
Company: PathAI
Title: Co-Founder and CEO
Andrew Beck is the Co-Founder and CEO of PathAI. PathAI’s services solve challenging pathology problems faced by the research and pharmaceutical industries. The PathAI platform provides end-to-end automation for reliable, scalable, and cost-effective long-term solutions. The company is developing technology that assists pathologists in making accurate diagnoses for patients.
Prior to co-founding PathAI, Beck was on the faculty of Harvard Medical School in the Department of Pathology at Beth Israel Deaconess Medical Center. He has published over 110 papers in the fields of cancer biology, cancer pathology, and biomedical informatics. He earned his MD from Brown Medical School and completed residency and fellowship training in anatomic pathology and molecular genetic pathology from Stanford University. He also completed a PhD in biomedical informatics from Stanford University, where he developed one of the first machine-learning-based systems for cancer pathology. He has been certified by the American Board of Pathology in Anatomic Pathology and Molecular Genetic Pathology.
14. Richard Yoo
Company: Lunit
Title: CTO
Richard Yoo is the CTO of Lunit. Lunit, abbreviated from “learning unit,” is a venture company devoted to developing advanced software for medical data analysis and interpretation via deep learning technology. The company's main area of expertise lies in processing medical imaging data. It envisions a near future when its systems will greatly help physicians make accurate, consistent, and efficient clinical decisions, not limited to diagnoses, through its data-driven imaging biomarker technology.
Yoo has over 10 years of experience in software development and management at leading tech companies such as Google and Intel. In particular, at Verily Life Sciences, a healthcare subsidiary of Google’s Alphabet, he has led various healthcare-related software development projects for several years. Yoo holds a bachelor's degree in electrical engineering from Seoul National University, a master's degree in electrical and computer engineering from the Georgia Institute of Technology, and a PhD in electrical engineering from Stanford University. He also holds a master's degree in biomedical informatics from Harvard Medical School.
15. Eron Kelly
Company: ConcertAI
Title: CEO
Eron Kelly is the CEO of ConcertAI, a healthcare technology company specializing in AI and real-world data solutions for the life sciences sector. Kelly joined ConcertAI from Inovalon, a cloud-based healthcare SaaS provider, where he served as president. During his tenure at Inovalon, he drove the company’s transformation into a pure-play cloud-based SaaS and DaaS provider while bringing new AI solutions into each business unit and achieving double-digit growth.
Prior to Inovalon, Kelly spent more than 20 years bringing new cloud products to market at both AWS and Microsoft. At AWS, he led worldwide product marketing for more than 40 services across six major categories that grew 250% during his tenure to $40 billion in revenue, and at Microsoft, he led the creation of Office 365 and helped grow it into a $13 billion business during his time in leadership roles in product management, sales, and marketing. Kelly graduated from Harvard Business School with an MBA and from Princeton University with a bachelor’s degree in electrical engineering.
16. Leila Pirhaji
Company: ReviveMed
Title: Co-Founder and CEO
Dr. Leila Pirhaji is the founder of ReviveMed, a company that emerged from her PhD research at MIT and focuses on applying metabolomics to precision medicine. She led the development of a first-in-class generative AI platform designed for large-scale metabolomics, combined with multi-omic network modeling. This approach enabled the creation of digital metabolic twins, facilitating biomarker discovery, patient stratification, and therapeutic innovation across oncology, metabolic, and autoimmune diseases.
Earlier in her career, Pirhaji conducted research at esteemed institutions such as ETH Zurich and contributed to drug development efforts at Merck and Takeda Pharmaceuticals. She remains committed to advancing AI-driven technologies that bridge complex biology with actionable clinical insights. Pirhaji graduated from the Massachusetts Institute of Technology with a PhD in biological and biosystems engineering and from the University of Tehran with a master’s degree and a bachelor’s degree in biotechnology.
17. Tanay Tandon
Company: Commure
Title: CEO
Tanay Tandon is the CEO of Commure, a company that aims to simplify healthcare by co-developing software solutions that address the many complex needs hospitals face. Through a purpose-built platform and a suite of interconnected AI-powered products, Commure streamlines workflows for providers, enhances patient experiences, and empowers administrators to increase hospital efficiency and profitability.
Prior to joining Commure, Tandon co-founded Athelas, where he served as CEO and helped build software tools to streamline operations for healthcare systems. He previously conducted research in Stanford’s AI Lab, focusing on computer vision and natural language processing, and held roles at early-stage companies including MetaMind, Wit.ai, and Clipped.me, where he developed deep learning models and NLP applications.
18. Lina Nilsson
Company: Recursion Pharmaceuticals
Title: SVP of Platform and Product
Lina Nilsson has been with Recursion since 2018 and is currently the SVP of Platform and Product, sitting on the executive leadership team. Recursion is a clinical-stage biotechnology company leading the space by decoding biology to radically improve lives. Enabling its mission is Recursion OS, an AI-driven platform built across diverse technologies that continuously generates one of the world’s largest proprietary biological and chemical datasets.
Previously, Nilsson was the COO of Enlitic, a biotech startup that develops deep learning solutions to improve clinical radiology. As innovation director at the University of California, Berkeley, she helped spin out social-impact technologies and develop entrepreneurial programs for students. She conceptualized and helped launch HardwareX, a peer-reviewed journal for open-source hardware that is hosted by Elsevier. Nilsson earned a PhD in biomedical engineering from ETH Zürich, a master’s degree in biomedical engineering from the University of Washington, and a bachelor’s degree in chemical engineering from Illinois Institute of Technology.
19. Louis Ciano
Company: Crosby Health
Title: Co-Founder and COO
Louis Ciano is the Co-Founder and COO of Crosby Health, a company focused on helping healthcare organizations manage insurance claim appeals. The company originated within a five-physician private practice, where the team developed internal tools to address a high volume of denials. After seeing early success, Ciano and his co-founders launched Crosby Health to serve a broader range of providers. Its proprietary AI platform, Apollo, automates clinical appeals by analyzing unstructured documentation and streamlining the process from initiation to submission.
Before joining Crosby Health, Ciano was a technical program manager at Meta. Ciano graduated from New York University with a bachelor’s degree in business and technology management, as well as physics and computer engineering.
20. Mike Dobbles
Company: egnite
Title: CTO
Mike Dobbles is the CTO of egnite, a data-centric digital health company committed to advancing the health of our society through cardiovascular solutions. egnite uses AI-driven algorithms and big data to produce business intelligence for healthcare, elevating the role of data in critical decisions. Dobbles has specialized in technology, analytics, and software throughout his career, which spans more than 30 years.
Prior to egnite, Dobbles served as senior director of engineering with Edwards Lifesciences, where he assembled and led a 22-person team of software and IT operations engineers that developed the CardioCare program. Previous to his tenure at Edwards Lifesciences, Dobbles led engineering teams developing continuous glucose monitoring systems for the diabetes market at Medtronic and Dexcom. Dobbles holds a bachelor’s degree in aerospace engineering from the University of Illinois Urbana-Champaign, a master’s degree in data analytics from Villanova University, and a master’s degree in bioinformatics from Johns Hopkins University.
21. Shirley Nickels
Company: SafelyYou
Title: COO
Shirley Nickels is the Chief Operating Officer of SafelyYou, a company developing ambient AI technologies for senior living care. SafelyYou initially focused on reducing falls among residents with dementia through its SafelyYou Respond platform, which has helped communities lower fall-related ER visits by up to 80%. Nickels leads strategy and execution across all revenue functions and has played a central role in shaping the company’s operations, customer journey, and market presence. Drawing on a track record of scaling B2B health-tech startups, she brings both business discipline and personal commitment to SafelyYou’s mission.
Nickels first got her start in 1999 as an operations manager at NetLojix. From there, she went on to serve as vice president of products at VIASANT, before eventually co-founding and serving as president at Sentact, her most recent position prior to joining SafelyYou. Nickels studied at the University of California, Santa Barbara.
22. Daniel Kozimor
Company: Enlitic
Title: CTO
Dan Kozimor has spent his entire career focusing on the human aspects of software engineering, using his extensive experience developing radiology information technology to evolve the process of reading medical images. As CTO at Enlitic, Kozimor leads the engineering and data science teams to develop the next generation of medical imaging software and find new ways to transform the future of healthcare. Kozimor specializes in scaling tech companies and enabling exceptional engineers to reimagine what healthcare can become.
Previously, Kozimor was a VP of engineering at Mach7 Technologies. Earlier in his career, he worked with Client Outlook Inc. as a VP of engineering and founder. Kozimor earned a master’s in computer science from the University of Waterloo and a bachelor’s degree in computer science from the University of Toronto.
23. Zak Beharie
Company: ODAIA Intelligence
Title: CTO
Zak Beharie is the CTO of ODAIA Intelligence. ODAIA is an AI company helping life sciences companies innovate their commercial engagement strategies using customer science. The company’s cloud solution, MAPTUAL, integrates data science, behavioral science, and AI to gain a deep understanding of healthcare professionals (HCPs) and their patient decisions across the entire customer journey. Beharie has over 20 years of experience in the IT industry and has led technical teams to deliver complex solutions for Morega, Ceridian, and Capital One.
Before joining ODAIA Intelligence, Beharie was a software engineering manager at Capital One and, before that, a R&D platform development manager at Ceridian Canada. Earlier in his career, he worked with ATI Technologies Inc. as a software engineer. Beharie graduated from the University of Waterloo with a bachelor’s degree in computer engineering.
24. Alexander Dresner
Company: Imagen
Title: Co-Founder and CEO
Alex Dresner is the Co-Founder and CEO of Imagen. Imagen’s mission is to enhance the accessibility, accuracy, and immediacy of frontline diagnostic imaging. Its Diagnostics-as-a-Service (DaaS) platform is designed to improve the patient experience and empower primary care physicians to make earlier, more accurate diagnoses to ultimately enable higher-quality care. The platform incorporates FDA-cleared AI tools to assist in interpreting medical images, helping clinicians detect conditions such as aortic disease directly from chest X-rays.
Prior to co-founding Imagen, Dresner worked as the head of the Hospital for Special Surgery’s Value Analytics and Management Office. Dresner began his career at Bridgewater Associates, where he was a member of the core management team. He received his bachelor’s degree from the London School of Economics.
25. Pranay Kapadia
Company: Notable
Title: Co-Founder and CEO
Pranay Kapadia is the Co-Founder and CEO of Notable. Notable is an AI platform for healthcare operations. Deployed at over 10,000 sites of care, Notable automates over a million repetitive workflows every day across registration and intake, scheduling and referrals, assistant, authorizations, care gap closure, and HCC chart review. Kapadia launched the company in 2017 with a focus on reducing administrative burdens so clinicians can spend more time on patient care. His background in computer science has shaped his approach to scalable, AI-driven solutions that address the complexity of healthcare delivery.
Kapadia first got his start in 2005 as a technical consultant at Oracle before eventually rising to his role as a Microsoft Partner, and then Head of Product for Mint.com and Mint Mobile at Intuit. Kapadia graduated from the Wisconsin School of Business with an MBA and from the University of Wisconsin-Madison with a bachelor’s degree in computer science.
